iShares US Pharmaceuticals ETF
IHE
IHE
101 hedge funds and large institutions have $139M invested in iShares US Pharmaceuticals ETF in 2018 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
44% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 16
51% less capital invested
Capital invested by funds: $285M → $139M (-$146M)
59% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 41
Holders
101
Holding in Top 10
1
Calls
$1.05M
Puts
$605K
Top Buyers
| 1 | +$2.85M | |
| 2 | +$2.32M | |
| 3 | +$650K | |
| 4 |
SB
Suntrust Banks
Atlanta,
Georgia
|
+$415K |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$402K |
Top Sellers
| 1 | -$116M | |
| 2 | -$8.2M | |
| 3 | -$4.7M | |
| 4 |
Jane Street
New York
|
-$3.35M |
| 5 |
AWA
ARS Wealth Advisors
St. Petersburg,
Florida
|
-$2.41M |